Rivian Automotive Option Alert: Sep 19 $16 Calls at the Bid: 5000 vs 10168 OI; Earnings 2/20 After Close 

Rivian Automotive Option Alert: Sep 19 $16 Calls at the Bid: 5000 @ $2.54 vs 10168 OI; Earnings 2/20 After Close Ref=$14.315

Rivian Automotive Option Alert: Jan, 2026 $7.5 Puts at the Bid: 8000 vs 63532 OI; Earnings 2/20 After Close 

Rivian Automotive Option Alert: Jan, 2026 $7.5 Puts at the Bid: 8000 @ $0.82 vs 63532 OI; Earnings 2/20 After Close Ref=$12.535

Rivian Automotive Option Alert: Sep 19 $16 Puts at the Bid: 2908 vs 160 OI; Earnings 2/20 After Close 

Rivian Automotive Option Alert: Sep 19 $16 Puts at the Bid: 2908 @ $4.75 vs 160 OI; Earnings 2/20 After Close Ref=$12.53

Rivian Automotive Option Alert: Feb 21 $12 Calls at the Bid: 7200 vs 6026 OI; Earnings 2/20 After Close 

Rivian Automotive Option Alert: Feb 21 $12 Calls at the Bid: 7200 @ $1.18 vs 6026 OI; Earnings 2/20 After Close Ref=$12.51

Rivian Automotive (NASDAQ:RIVN) Stock

Rivian Automotive

Rivian Automotive Inc designs, develops, and manufactures category-defining electric vehicles and accessories. In the consumer market, the company launched the R1 platform with the first generation of consumer vehicles: the R1T, a two-row, five-passenger pickup truck, and the R1S, a three-row, seven-passenger sport utility vehicle (SUV).

Rivian Automotive Inc.

Equities

News

Markets

RIVN

TSLA

Rivian Automotive Inc.&#39;s $6.6 billion federal loan for its planned electric vehicle manufacturing plant in Georgia hangs in the balance following recent actions by the President Donald Trump administration.

Tesla-Rival Rivian&#39;s $6.6 Billion Federal Loan Under Scrutiny As Trump Administration Reviews Funding

Closeup,Of,Wall,St.,Street,Sign,And,Large,New,York

Government

Treasuries

Economics

Pre-Market Outlook

Analyst Ratings

APTO

BABA

BIDU

CVNA

MGOL

U.S. stock futures rose on Tuesday following a mixed close on Friday after the Presidents&#39; Day holiday on Monday.

US Stocks Likely To Open Higher Amid Ukraine Peace Talk Hopes As Russian, American Officials Meet

What Happened

Tech

California-based EV startup Rivian Automotive on Tuesday released a series of teaser images, accompanied by the message &#34;a mirage takes shape Feb 19.&#34;

MKBHD Joins Guessing Game After Rivian Teases &#39;Mirage&#39; Event For Feb. 19: What&#39;s Going On?

Rivian Automotive, Inc. - Class A Common Stock

Rivian Automotive Inc

On Wednesday, Precision BioSciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) revealed initial results from the first administration of PBGENE-HBV in cohort 1, the lowest dose level <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43808780/precision-biosciences-announces-initial-safety-and-antiviral-activity-of-pbgene-hbv-in-the-elimina" rel="noreferrer noopener">of the ELIMINATE-B trial</a>.
The ELIMINATE-B trial is designed to investigate PBGENE-HBV at multiple ascending dose levels with three dose administrations per dose level in chronic Hepatitis B patients who are HBeAg-negative.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42924720/precision-biosciences-gene-editing-platform-has-differentiated-mechanism-and-is-potentially-competitive-analyst" rel="noreferrer noopener">Precision BioSciences&#8217; Gene Editing Platform Has Differentiated Mechanism, And Is Potentially Competitive: Analyst</a>
PBGENE-HBV, which comprises an ARCUS-encoding mRNA encapsulated in a lipid nanoparticle (LNP), was safe and well tolerated in all three cohort 1 participants after the first administration of a 0.2 mg/kg dose. The planned dosing schedule in ELIMINATE-B allows for two additional administrations at this dose level while simultaneously investigating the next higher dose level.
Across the three participants dosed, none experienced a Grade ≥2 treatment-related adverse event or serious adverse event.
In addition to safety, PBGENE-HBV demonstrated a substantial reduction in Hepatitis B surface antigen (HBsAg) in two of the three participants following the first administration at dose level 1.
With a well-tolerated safety profile and early antiviral activity established at pre-specified time points, Precision will complete subsequent administrations in all cohort 1 patients.
The ELIMINATE-B study is currently enrolling HBeAg-negative chronic Hepatitis B patients at sites in Moldova, Hong Kong, and New Zealand.
The company is on schedule to provide additional administrations at this dose level and subsequently plans to escalate to higher dose levels to define the optimal dose and number of dose administrations for safely eliminating covalently closed circular DNA (cccDNA)&nbsp;and inactivating integrated HBV DNA.
Precision plans to share detailed clinical data throughout 2025. HC Wainwright analyst Patrick Trucchio reiterates Precision BioSciences with a Buy and maintains a $60 price target.
Price Action: DTIL stock is up 9.22% at $5.63 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/02/43817640/philips-stock-falls-as-china-weakness-drags-q4-earnings-2025-outlook" target="_blank" rel="noreferrer noopener">Philips Stock Falls As China Weakness Drags Q4 Earnings, 2025 Outlook</a></li>
</ul>

Biotech

Health Care

Movers

Trading Ideas

General

DTIL

Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate

BlackRock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) shares are trading <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">relatively flat on Wednesday.</a>
The company has reportedly canceled meetings with companies amid U.S. Securities and Exchange Commission&#8217;s new investor activism rules, raising concerns over the future of environmental, social, and governance engagement, The Financial Times <a target="_blank" href="https://www.ft.com/content/533f9322-f098-4b82-823f-a7a8ef9350f1" rel="noreferrer noopener">reports</a>.
The SEC&#8217;s recent rule changes, which target the influence of ESG factors in investing, have forced BlackRock to pause its usual &#8220;stewardship&#8221; meetings while it assesses the new regulatory landscape, the report adds, citing people familiar with the discussions.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, BLK stock has gained over 22% in the past year. Investors can gain exposure to the stock via&nbsp;Fidelity Disruptive Finance ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDFF#NASDAQ">FDFF</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43816112/hedge-fund-shake-up-tiger-appaloosa-soros-outperform-buffett-icahn-ackman" rel="noreferrer noopener">Hedge Fund Shake-Up: Tiger, Appaloosa, Soros Outperform Buffett, Icahn, Ackman</a>
The SEC&#8217;s updated guidelines impose more stringent requirements on fund managers who aim to influence corporate behavior, such as pressing for changes in executive compensation or promoting climate risk disclosures.
Previously, managers owning more than 5% of a company could file a relatively simple 13-G form, but now they may need to file a 13-D, triggering more complex disclosures and deadlines.
This regulatory shift complicates BlackRock&#8217;s ability to engage on key ESG topics and undermines efforts to address corporate governance issues like poison pill plans, the report further notes.
The rule changes have drawn criticism for curbing the power of fund managers to press companies on social and environmental issues, especially as conservative lawmakers intensify pressure on firms like BlackRock over their perceived influence on corporate America.
As BlackRock and other asset managers navigate these new requirements, the broader impact on ESG investing and corporate governance remains unclear.
Price Action: BLK shares are trading higher by 0.86% to $986.23 at last check Wednesday.
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43766008/berkshire-hathaways-13f-filing-suggests-a-buffett-style-bash-pizza-beer-and-fine-wine" target="_blank" rel="noreferrer noopener">Berkshire Hathaway&#8217;s 13F Filing Suggests a Buffett-Style Bash — Pizza, Beer and Fine Wine</a></li>
</ul>
Photo by rafapress on Shutterstock.

Media

FDFF

What's Going On With BlackRock Stock Today?

On Wednesday, Harmony Biosciences Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRMY#NASDAQ">HRMY</a>) received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for pitolisant for excessive daytime sleepiness (EDS) in adult patients <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43810390/harmony-biosciences-provides-update-on-the-status-of-the-supplemental-new-drug-application-for-pit" rel="noreferrer noopener">with idiopathic hypersomnia (IH)</a>.
Harmony&#8217;s 2025 net revenue guidance of $820 million-$860 million remains unchanged.
&#8220;We are disappointed with this short-term setback, but our long-term strategy for pitolisant in IH remains firmly on track with our focus on Pitolisant HD,&#8221; said Jeffrey M. Dayno, President and Chief Executive Officer of Harmony Biosciences. &#8220;We are on track to initiate a Phase 3 registrational trial of Pitolisant HD in IH in Q4 2025, with a target PDUFA date in 2028.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40802152/neurology-focused-harmony-biosciences-gains-confidence-with-wakix-sales-surge-strat" rel="noreferrer noopener">Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says</a>
Although the primary outcome for excessive daytime sleepiness (EDS) between pitolisant and placebo did not reach statistical significance in the randomized withdrawal phase of the Phase 3 INTUNE Study, the data from the open-label phase showed that patients experienced improvements on the Epworth Sleepiness Scale that were five times greater than what is recognized as clinically meaningful.
Furthermore, most patients in the long-term extension study achieved normal levels of wakefulness and sustained this response beyond one year.
Pitolisant is marketed as Wakix&nbsp;in the U.S. for EDS or cataplexy in adult patients with narcolepsy and for EDS in pediatric patients 6 years of age and older with narcolepsy.&nbsp;It is not currently approved for IH.
In January, the company reported preliminary net product revenue for the fourth quarter of approximately $201 million, compared to $168.4 million a year ago and the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $198.6 million</a>.
The average number of patients on Wakix increased by approximately 300 sequentially to approximately 7,100 for the quarter <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42942961/harmony-biosciences-reports-strong-2024-revenues-provides-2025-revenue-guidance-and-highlights-key" rel="noreferrer noopener">ended December 31, 2024</a>.
Needham analyst Ami Fadia maintains Harmony Biosciences with a Buy and lowers the price <a target="_blank" href="https://www.benzinga.com/quote/HRMY/analyst-ratings" rel="noreferrer noopener">target from $52 to $50</a>.
Price Action: HRMY stock is down 6.50% at $36.55 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43815970/ai-meets-water-palantir-partners-with-saur-for-smarter-contract-management" target="_blank" rel="noreferrer noopener">Palantir Strikes AI Deal With SAUR For Contract Management: Details</a></li>
</ul>

HRMY

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder

Blockstream CEO Adam Back believes Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is entering a fresh bull market, citing strong inflows from ETFs <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43790066/institutions-can-earn-bitcoin-yield-with-lstbtc-while-retaining-custodian-security">and institutional investors.</a>
What Happened: "We're certainly in the early stages of a bull market," Back <a href="https://x.com/Cointelegraph/status/1892255600119001153">told</a> CNBC on Wednesday, emphasizing the growing demand for Bitcoin among financial institutions.
Back highlighted that Bitcoin ETFs are currently absorbing twice the daily mined supply, with firms like MicroStrategy further adding to the buying pressure. 
"Really, there's a lot of inflow," he said, adding that despite short-term profit-taking by midterm investors, structural demand remains robust.
Bitcoin is currently trading at $96,000, gaining 2% for the day, while Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is up 3% at $2,705.
Other major cryptocurrencies are also rallying, with BNB (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>) up 2.5%, Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) up 3.5% to $170.5, and Litecoin (CRYPTO: LITE) surging 8%. 
Meme coins Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) and Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) are trading flat.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43816143/study-shows-reasons-why-bitcoin-ethereum-dogecoin-shiba-inu-plummet-from-their-all-time-highs">Study Shows Reasons Why Bitcoin, Ethereum, Dogecoin, Shiba Inu Plummet From Their All-Time Highs</a>
Why It Matters: Back noted that institutional adoption is accelerating, with ETF 13F filings revealing that 30% of Bitcoin ETF buyers are institutions.
He expects pension and mutual funds to increase their allocations in the coming cycle. "There's a lot of room for capital to come in," he said.
Additionally, Back suggested Bitcoin could soon compete with gold ETFs as capital reallocates from traditional safe-haven assets. 
He also pointed to sovereign treasuries as a potential catalyst, stating that if one major nation adds Bitcoin to reserves, "others will feel forced to follow suit."
With institutional capital and treasury investments increasing, the market could be poised for further gains, reinforcing Back's view that Bitcoin remains in the early innings of a sustained rally.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43815939/binanceus-restores-usd-services-after-lengthy-regulatory-roadblock">Binance.US Restores USD Services After Lengthy Regulatory Roadblock</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BNB

$BTC

$DOGE

$SHIB

$SOL

Bitcoin 'Early In Bull Market,' Can Compete With Gold ETFs, Blockstream CEO Says

WIIM

Eason Technology shares are trading higher after the company announced it has acquired Hongkong Starlux Intelligent Technology.

Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk.
Looking at options history for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $136,075 and 10, calls, for a total amount of $989,743.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $70.0 to $125.0 for Novo Nordisk during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $70.0 to $125.0 in the last 30 days. 
<h3>Novo Nordisk Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739992546_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$5.3</td>
<td>$5.0</td>
<td>$5.05</td>
<td>$110.00</td>
<td>$606.0K</td>
<td>1.9K</td>
<td>1.2K</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$18.0</td>
<td>$17.8</td>
<td>$18.0</td>
<td>$95.00</td>
<td>$106.2K</td>
<td>601</td>
<td>60</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$5.65</td>
<td>$5.55</td>
<td>$5.55</td>
<td>$85.00</td>
<td>$73.2K</td>
<td>2.1K</td>
<td>95</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$18.0</td>
<td>$17.8</td>
<td>$17.8</td>
<td>$75.00</td>
<td>$53.4K</td>
<td>199</td>
<td>2</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$14.95</td>
<td>$14.7</td>
<td>$14.85</td>
<td>$70.00</td>
<td>$46.0K</td>
<td>44</td>
<td>31</td>
</tr>
</tbody>
</table>

<h3>About Novo Nordisk</h3>
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Novo Nordisk Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 3,760,951, the NVO's price is up by 1.01%, now at $83.16. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 77 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novo Nordisk options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Intuit.
Looking at options history for Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) we detected 13 trades.
If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish expectations and 30% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $351,320 and 5, calls, for a total amount of $362,470.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $530.0 and $670.0 for Intuit, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Intuit options trades today is 185.6 with a total volume of 128.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Intuit's big money trades within a strike price range of $530.0 to $670.0 over the last 30 days.
<h3>Intuit Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739992541_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$19.8</td>
<td>$18.0</td>
<td>$18.0</td>
<td>$565.00</td>
<td>$173.0K</td>
<td align="right">147</td>
<td align="right">10</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$72.4</td>
<td>$64.4</td>
<td>$70.0</td>
<td>$600.00</td>
<td>$126.0K</td>
<td align="right">303</td>
<td align="right">0</td>
</tr>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$104.0</td>
<td>$99.0</td>
<td>$99.0</td>
<td>$610.00</td>
<td>$99.0K</td>
<td align="right">20</td>
<td align="right">10</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$25.8</td>
<td>$24.9</td>
<td>$25.8</td>
<td>$580.00</td>
<td>$38.7K</td>
<td align="right">387</td>
<td align="right">48</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$24.8</td>
<td>$24.5</td>
<td>$24.5</td>
<td>$580.00</td>
<td>$36.7K</td>
<td align="right">387</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Intuit</h3>
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of US market share for small-business accounting and do-it-yourself tax-filing software.
<h3>Where Is Intuit Standing Right Now?</h3>
<ul>
<li>With a volume of 914,340, the price of INTU is down -0.59% at $576.52. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 6 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuit with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

INTU

Check Out What Whales Are Doing With INTU

Whales with a lot of money to spend have taken a noticeably bullish stance on Roblox.
Looking at options history for Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 42% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $221,365 and 8, calls, for a total amount of $315,360.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $79.0 for Roblox during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Roblox stands at 1006.23, with a total volume reaching 1,126.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Roblox, situated within the strike price corridor from $30.0 to $79.0, throughout the last 30 days.
<h3>Roblox Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739992536_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$15.6</td>
<td>$15.15</td>
<td>$15.6</td>
<td>$52.50</td>
<td>$68.6K</td>
<td>106</td>
<td align="right">1</td>
</tr>
<tr>
<td>RBLX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$4.35</td>
<td>$4.3</td>
<td>$4.3</td>
<td>$65.00</td>
<td>$45.5K</td>
<td>1.7K</td>
<td align="right">110</td>
</tr>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$22.55</td>
<td>$21.85</td>
<td>$22.32</td>
<td>$45.00</td>
<td>$44.6K</td>
<td>144</td>
<td align="right">20</td>
</tr>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$6.9</td>
<td>$6.8</td>
<td>$6.8</td>
<td>$72.50</td>
<td>$43.5K</td>
<td>456</td>
<td align="right">64</td>
</tr>
<tr>
<td>RBLX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/07/25</td>
<td>$14.5</td>
<td>$14.3</td>
<td>$14.3</td>
<td>$79.00</td>
<td>$42.9K</td>
<td>1</td>
<td align="right">30</td>
</tr>
</tbody>
</table>

<h3>About Roblox</h3>
Roblox operates an online video game platform with 80 million daily active users that lets young gamers create, develop, and monetize games (or "experiences") for other players. The firm offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning $3.5 billion in bookings in 2023 through in-game purchases and advertising while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers than creating new games or franchises.
After a thorough review of the options trading surrounding Roblox, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Roblox Standing Right Now?</h3>
<ul>
<li>With a trading volume of 2,865,542, the price of RBLX is down by -3.28%, reaching $63.93.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 78 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Roblox</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $69.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Roblox, maintaining a target price of $82. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Overweight with a new price target of $72. 
&#x2A; Maintaining their stance, an analyst from Roth MKM continues to hold a Neutral rating for Roblox, targeting a price of $70. 
&#x2A; An analyst from Macquarie has decided to maintain their Outperform rating on Roblox, which currently sits at a price target of $76. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Roblox, targeting a price of $46. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Roblox, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

RBLX

Roblox's Options: A Look at What the Big Money is Thinking

Shares of Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) are off slightly ahead of tomorrow's report. The company will release its earnings tomorrow and is scheduled to have a conference call at 7:30 AM EST to discuss the results.
Even if the earnings are good, there is a chance that the stock heads lower. This is why it is our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.
BABA has rallied by about 60% in just a few weeks. Analysts attribute this move to <a href="https://www.benzinga.com/general/market-summary/25/02/43806017/alibabas-q4-shakeup-many-asian-funds-exit-while-us-based-funds-like-ubs-oconnor-marathon-assetmark-cantor-fitzgerald-double-down">optimism around AI advancement.</a>
This could set the stage for what traders call a ‘crowded trade'. This would be bearish for the stock.
It means that because investors think the earnings will be good, the vast majority purchase shares ahead of the release. This makes the market effectively run out of buyers.
Stocks don't move higher unless traders and investors who wish to buy push the price up. A market with no buyers can't go up.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43816112/hedge-fund-shake-up-tiger-appaloosa-soros-outperform-buffett-icahn-ackman">Hedge Fund Shake-Up: Tiger, Appaloosa, Soros Outperform Buffett, Icahn, Ackman</a>
If the earnings are good and the stock doesn't rally, some will become concerned and may decide to sell.&nbsp; But they will have a hard time finding buyers for their shares. They may need to push the price lower.
Others will see this and may decide to do the same. It could result in a snowball effect that results in a selloff even if the numbers beat expectations.
Technically, as you can see on the chart below, Alibaba is also extremely overbought.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="545" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119-1024x545.png" alt="" class="wp-image-789703" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119-1024x545.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119-768x409.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119.png 1518w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
This means the stock is trading above what would be its typical or normal range. Some technical traders will be anticipating a reversion to the mean or move lower. They may enter the market as sellers and this could put downward pressure on the stock.
The shares are also testing resistance around $124.00. The last three times they hit this level a selloff followed.
Resistance is a price level where there is a large amount of sell interest. Stocks can sell off of resistance if some of the people who created the resistance become willing to accept lower prices and start to undercut each other.
Excessive optimism about the earnings release, being overbought, and being at resistance means BABA may be about to head lower. Even if the earnings are good.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/travel/25/02/43814828/life-threatening-cold-air-snow-brings-travel-delays-higher-heating-costs">&#8216;Life-Threatening&#8217; Cold Air, Snow Brings Travel Delays, Higher Heating Costs</a></li>
</ul>
Image: Shutterstock

Technicals

Stock Of The Day: Will A 'Crowded Trade' Force Alibaba Lower?

Aptose Biosciences shares are trading lower after the company announced a 1-for-30 reverse stock split.

WOOF

Petco Health and Wellness shares are trading lower. The company announced leadership changes at the company including the CFO.

Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) shares traded higher on Wednesday after the company revealed <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">its long-term growth targets.</a>
The company <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/43493897/versace-jimmy-choo-parent-capri-q3-earnings-miss-sales-decline-lackluster-outlook-more" rel="noreferrer noopener">reiterated </a>its FY25 revenues projections at $4.4 billion <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43812171/capri-holdings-announces-long-term-financial-targets" rel="noreferrer noopener">versus the $4.465 billion estimate</a>. Revenues are expected to be $4.1 billion in FY26 and $4.4 billion in FY27.
John D. Idol, the Company&#8217;s Chairman and Chief Executive Officer, said, &#8220;We are optimistic about the long-term growth potential for Versace, Jimmy Choo and Michael Kors as we execute our strategic initiatives.&#8221;
For 2025, Michael Kors is projected to generate $3.0 billion in revenue. Versace is expected to achieve $810 million in revenue. Jimmy Choo&#8217;s revenue is forecasted to reach $600 million.
Also Read:<a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/02/43818486/yum-brands-moves-kfcs-us-headquarters-to-texas-in-strategic-shift" rel="noreferrer noopener"> Yum! Brands Moves KFC&#8217;s US Headquarters To Texas In Strategic Shift</a>
For FY25, the company projects an adjusted operating margin of 2.3%. The adjusted operating margin is expected to rise to 3.7% for FY26.
For FY25, Michael Kors is expected to have a low double-digit operating margin. Versace is projected to have a negative high single-digit operating margin. Jimmy Choo&#8217;s operating margin is anticipated to be in the negative low single-digit range.
&#8220;Our powerful brands have enduring value and proven resilience, reinforcing our confidence in their ability to deliver revenue and earnings growth over time,&#8221; Idol adds.
In November last year, Tapestry, Inc. terminated the merger agreement with Capri, citing <a target="_blank" href="https://www.benzinga.com//node/41971497" rel="noreferrer noopener">uncertainty in the legal process.</a>
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, CPRI stock has lost over 53% in the past year. Investors can gain exposure to the stock via Elevation Series Trust Clough Select Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBSE#NYSE">CBSE</a>).
Price Action: CPRI shares are trading higher by 2.28% to $22.00 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43813431/e-commerce-company-etsy-q4-earnings-sales-miss-pressured-consumer-spending-active-buyers-dip-and-more" target="_blank" rel="noreferrer noopener">E-Commerce Company Etsy Q4 Earnings: Sales Miss, Pressured Consumer Spending, Active Buyers Dip And More</a></li>
</ul>
Photo: Giorgio Borelli/Shutterstock.com.

Guidance

Changebridge Capital Sustainable Equity ETF

CBSE

CPRI

Why Is Fashion Luxury Company Capri Stock Gaining Today?

FVRR

Fiverr shares are trading lower after the company reported Q4 financial results and missed its adjusted EPS estimate.

CVEO

Civeo shares are trading higher after the company announced it acquired four mining villages in the Bowen Basin for $67 million.

Diversified Energy shares are trading lower after the company announced plans for a public offering of 8.5 million shares.

Macro Economic Events

Federal Reserve

FOMC Minutes: 'The risks around the baseline projection for inflation were seen as skewed to the upside because core inflation had not come down as much as expected in 2024 and because changes to trade policy could put more upward pressure on inflation than the staff had assumed.'

FOMC Minutes: 'In particular, participants cited the possible effects of potential changes in trade and immigration policy, the potential for geopolitical developments to disrupt supply chains, or stronger-than-expected household spending'

SOHU

Sohu.Com shares are trading higher. The stock may be moving on continued strength after the company reported yesterday a year-over-year increase in Q4 PC and mobile monthly active users (MAUs).

FOMC Minutes Show Officials Saw Higher Uncertainty Warranting Careful Approach On Cuts; Majority Of Officials Saw Inflation, Employment Risks As 'Roughly in Balance'

SAND

Sandstorm Gold shares are trading lower after the company reported worse-than-expected Q4 EPS results and HC Wainwright & Co. cut its price target on the stock from $12 to $11.5.

Commodities

Small Cap

Opinion

Press Releases

Record Investments Needed in Renewable Tech and Mining to Hit Global Emission Targets

Rivian Releases Third Quarter 2024 Financial Results

Rivian to Participate in Baird's Global Industrial Conference

Faster, Leaner, More Efficient: Rivian and Volkswagen Group Announce the Launch of their Joint Venture

Rivian Receives Conditional Commitment for up to $6.6 Billion Loan from the U.S. Department of Energy's Advanced Technology Vehicle Manufacturing (ATVM) Program

Entertainment

Rivian owners receive three-month trial subscription to SiriusXM Canada's comprehensive audio entertainment offering

Rivian Releases Q4 2024 Production and Delivery Figures and Sets Date for Fourth Quarter and Full Year 2024 Results

Rivian and U.S. Department of Energy Finalize Loan Agreement to Support Future Georgia Manufacturing Site

Rivian Opens Sales of The Rivian Commercial Van to Fleets of All Sizes in The US

Rivian Certified Collision Network Grants Approval for the Autel IA900 ADAS Calibration System

AEIS

AMPX

BATXF

CSE:BATX

Cenntro

Chijet Motor Company, Inc. - Ordinary Shares

Chijet Motor Co

ECD Automotive Design, Inc. - Common Stock

ECD Automotive Design

Ford Motor

Faraday Future Intelligent Electric Inc. - Class A Common Stock

Faraday Future

Fly-E Group

General Motors

Honda Motor Co

Lucid Gr

Li Auto Inc. - American Depositary Shares

Li Auto

Lotus Technology Inc. - American Depositary Shares

Lotus Technology

Mullen Automotive

NIO Inc. American depositary shares, each representing one Class A ordinary share

NWTN

Phoenix Motor

Polestar Automotive Holding UK Limited - Class A ADS

Polestar Automotive

Polestar Automotive Holding UK Limited - Class C-1 ADS (ADW)

Thor Industries

Toyota Motor

Tesla

VinFast Auto

Winnebago Industries

Workhorse Gr

XPeng Inc. American depositary shares, each representing two Class A ordinary shares

XPeng

ZEEKR Intelligent Technology Holding Limited American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

Rivian Automotive

Unusual Options Activity for

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
03:13 PMFeb 18, 2025	CALL	$16.00	Sep 19, 2025	211	5148	5000	51	10168	TRADE	BEARISH
02:15 PMFeb 12, 2025	PUT	$7.50	Jan 16, 2026	330	8000	8000	13	63532	TRADE	BEARISH
11:40 AMFeb 12, 2025	PUT	$16.00	Sep 19, 2025	211	2908	2908	1818	160	TRADE	BULLISH
11:18 AMFeb 12, 2025	CALL	$12.00	Feb 21, 2025	1	7304	7200	121	6026	TRADE	BEARISH